[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575678":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":297,"collaborators":26,"id":299,"slug":300,"hasResults":301,"nctId":302,"briefTitle":303,"officialTitle":304,"acronym":26,"eligibilityCriteria":305,"healthyVolunteers":301,"sex":306,"minAge":307,"maxAge":308,"enrollmentInfo":309,"targetDuration":26,"studyType":312,"phases":313,"briefSummary":315,"conditions":316,"keywords":26,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":318,"lastUpdatePostDateStruct":319,"startDateStruct":322,"completionDateStruct":324,"leadSponsor":326,"locationsCount":327},{"fullName":5,"class":6},"Shanghai Ark Biopharmaceutical Co., Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active drug","EXPERIMENTAL","The participants will receive AK0529 of 10 mg, 20 mg or 40 mg based on body weight twice daily for 5 days from D1 to D5.",[13],"Drug: AK0529",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","The participants will receive placebo of 10 mg, 20 mg or 40 mg based on body weight twice daily for 5 days from D1 to D5.",[19],"Drug: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","AK0529","Active Substance: AK0529, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Active Substance: Placebo, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Chao Yu, Master","CONTACT","+86 021-50681677","chao.yu@arkbiosciences.com",[37,57,68,83,98,113,128,143,158,170,184,199,211,226,240,255,270,282],{"facility":38,"status":39,"city":40,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Beijing Children's Hospital, Capital Medical University","RECRUITING","Beijing","China","CN",{"type":44,"coordinates":45},"Point",[46,47],116.39723,39.9075,{"lat":47,"lon":46},[50,54,56],{"name":51,"role":33,"phone":52,"phoneExt":26,"email":53},"Xin Ni, MD, PhD","+86 010-59612345","nixin@bch.com.cn",{"name":55,"role":33,"phone":26,"phoneExt":26,"email":26},"Shunying Zhao, MD, PhD",{"name":51,"role":33,"phone":26,"phoneExt":26,"email":26},{"facility":38,"status":39,"city":40,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},{"type":44,"coordinates":59},[46,47],{"lat":47,"lon":46},[62,65,67],{"name":63,"role":33,"phone":64,"phoneExt":26,"email":53},"Xin Ni","+86-010 59612345",{"name":66,"role":33,"phone":26,"phoneExt":26,"email":26},"Shunying Zhao",{"name":63,"role":33,"phone":26,"phoneExt":26,"email":26},{"facility":69,"status":39,"city":70,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"First Hospital of Jilin University","Changchun",{"type":44,"coordinates":72},[73,74],125.32278,43.88,{"lat":74,"lon":73},[77,81],{"name":78,"role":33,"phone":79,"phoneExt":26,"email":80},"Hongmei Qiao, MD, PhD","+86 0431-88782222","qiaohongmei0518@hotmail.com",{"name":82,"role":33,"phone":26,"phoneExt":26,"email":26},"Hongmei Qiao",{"facility":84,"status":39,"city":85,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Hunan Provincial People's Hospital","Changsha",{"type":44,"coordinates":87},[88,89],112.97087,28.19874,{"lat":89,"lon":88},[92,96],{"name":93,"role":33,"phone":94,"phoneExt":26,"email":95},"Lili Zhong, MD, PhD","+86 0731-83929900","zll_2024@163.com",{"name":97,"role":33,"phone":26,"phoneExt":26,"email":26},"Lili Zhong",{"facility":99,"status":39,"city":100,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"West China Second University Hospital, Sichuan University","Chengdu",{"type":44,"coordinates":102},[103,104],104.06667,30.66667,{"lat":104,"lon":103},[107,111],{"name":108,"role":33,"phone":109,"phoneExt":26,"email":110},"Hanmin Liu, MD, PhD","+86 028-88570307","hanmin@vip.163.com",{"name":112,"role":33,"phone":26,"phoneExt":26,"email":26},"Hanmin Liu",{"facility":114,"status":39,"city":115,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Children's Hospital, Zhejiang University School of Medicine","Hangzhou",{"type":44,"coordinates":117},[118,119],120.16142,30.29365,{"lat":119,"lon":118},[122,126],{"name":123,"role":33,"phone":124,"phoneExt":26,"email":125},"Zhimin Chen, MD, PhD","+86 0571-87061007","chenzhimin6@163.com",{"name":127,"role":33,"phone":26,"phoneExt":26,"email":26},"Zhimin Chen",{"facility":129,"status":39,"city":130,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":131,"geoPoint":135,"contacts":136},"Sanya Central Hospital, Hainan Third People's Hospital","Sanya",{"type":44,"coordinates":132},[133,134],109.50947,18.25435,{"lat":134,"lon":133},[137,141],{"name":138,"role":33,"phone":139,"phoneExt":26,"email":140},"Hua Zhang, MD, PhD","+86 0898-38220187","yue_liang2024@163.com",{"name":142,"role":33,"phone":26,"phoneExt":26,"email":26},"Hua Zhang",{"facility":144,"status":39,"city":145,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Shanghai Children's Hospital, Shanghai Jiao Tong University","Shanghai",{"type":44,"coordinates":147},[148,149],121.45806,31.22222,{"lat":149,"lon":148},[152,156],{"name":153,"role":33,"phone":154,"phoneExt":26,"email":155},"Xiaoyan Dong, MD, PhD","+86 021-52976017","dongxy@shchildren.com.cn",{"name":157,"role":33,"phone":26,"phoneExt":26,"email":26},"Xiaoyan Dong",{"facility":159,"status":39,"city":145,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":160,"geoPoint":162,"contacts":163},"Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine",{"type":44,"coordinates":161},[148,149],{"lat":149,"lon":148},[164,168],{"name":165,"role":33,"phone":166,"phoneExt":26,"email":167},"Yong Yin, MD, PhD","+86 021-38626161","yinyong9999@163.com",{"name":169,"role":33,"phone":26,"phoneExt":26,"email":26},"Yong Yin",{"facility":171,"status":39,"city":172,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"Shengjing Hospital of China Medical University","Shenyang",{"type":44,"coordinates":174},[175,176],123.43278,41.79222,{"lat":176,"lon":175},[179,183],{"name":180,"role":33,"phone":181,"phoneExt":26,"email":182},"Yunxiao Shang","+86 024 96615","yxshang@cmu.edu.cn",{"name":180,"role":33,"phone":26,"phoneExt":26,"email":26},{"facility":185,"status":39,"city":186,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":187,"geoPoint":191,"contacts":192},"Tianjin Children's Hospital（Longyan）","Tianjin",{"type":44,"coordinates":188},[189,190],117.17667,39.14222,{"lat":190,"lon":189},[193,197],{"name":194,"role":33,"phone":195,"phoneExt":26,"email":196},"Yongsheng Xu, MD, PhD","+86 022-87787101","xxyyss@126.com",{"name":198,"role":33,"phone":26,"phoneExt":26,"email":26},"Yongsheng Xu",{"facility":200,"status":39,"city":186,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":201,"geoPoint":203,"contacts":204},"Tianjin Children's Hospital（Machang）",{"type":44,"coordinates":202},[189,190],{"lat":190,"lon":189},[205,209],{"name":206,"role":33,"phone":207,"phoneExt":26,"email":208},"Yingxue Zou, MD, PhD","+86 022-23519459","zouyingxue2015@126.com",{"name":210,"role":33,"phone":26,"phoneExt":26,"email":26},"Yingxue Zou",{"facility":212,"status":39,"city":213,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University","Wenzhou",{"type":44,"coordinates":215},[216,217],120.66682,27.99942,{"lat":217,"lon":216},[220,224],{"name":221,"role":33,"phone":222,"phoneExt":26,"email":223},"Hailin Zhang, MD, PhD","+86 0577 - 88002682","zhlwz97@hotmail.com",{"name":225,"role":33,"phone":26,"phoneExt":26,"email":26},"Hailin Zhang",{"facility":227,"status":39,"city":228,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":229,"geoPoint":233,"contacts":234},"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan",{"type":44,"coordinates":230},[231,232],114.26667,30.58333,{"lat":232,"lon":231},[235,239],{"name":236,"role":33,"phone":237,"phoneExt":26,"email":238},"Xiaoxia Lu","+86 027-82433350","lusi74@163.com",{"name":236,"role":33,"phone":26,"phoneExt":26,"email":26},{"facility":241,"status":39,"city":242,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":243,"geoPoint":247,"contacts":248},"Wuxi Children's Hospital","Wuxi",{"type":44,"coordinates":244},[245,246],120.28857,31.56887,{"lat":246,"lon":245},[249,253],{"name":250,"role":33,"phone":251,"phoneExt":26,"email":252},"Ling Li, MD, PhD","+86 0510-85350188","sy333345@163.com",{"name":254,"role":33,"phone":26,"phoneExt":26,"email":26},"Ling Li",{"facility":256,"status":39,"city":257,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"First Affiliated Hospital of Xiamen University","Xiamen",{"type":44,"coordinates":259},[260,261],118.08187,24.47979,{"lat":261,"lon":260},[264,268],{"name":265,"role":33,"phone":266,"phoneExt":26,"email":267},"Yungang Yang, MD, PhD","+86 0592-2132222","xmyyg@xmu.edu.cn",{"name":269,"role":33,"phone":26,"phoneExt":26,"email":26},"Yungang Yang",{"facility":271,"status":39,"city":257,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":272,"geoPoint":274,"contacts":275},"Women and Children's Hospital, and the School of Medicine, Xiamen University",{"type":44,"coordinates":273},[260,261],{"lat":261,"lon":260},[276,280],{"name":277,"role":33,"phone":278,"phoneExt":26,"email":279},"Tong Shen, MD, PhD","+86 0592-2662020","xmshentong@163.com",{"name":281,"role":33,"phone":26,"phoneExt":26,"email":26},"Tong Shen",{"facility":283,"status":39,"city":284,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":285,"geoPoint":289,"contacts":290},"Zhongshan Women and Children's Hospital-Zhongshan Boai Hospital","Zhongshan",{"type":44,"coordinates":286},[287,288],113.37912,22.52306,{"lat":288,"lon":287},[291,295],{"name":292,"role":33,"phone":293,"phoneExt":26,"email":294},"Dongming Huang, MD, PhD","+86 0760-88306123","zhshhdm@126.com",{"name":296,"role":33,"phone":26,"phoneExt":26,"email":26},"Dongming Huang",{"type":298,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100575678","phase-3-a-study-to-confirm-the-effectiveness-and-safety-of-ak0529-in-treating-rsv-infections-in-hospitalized-infants-100575678",false,"NCT06775405","A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants","A Randomized, Double-blind, Placebo-controlled, Phase III Confirmatory Study to Evaluate the Efficacy, Safety, Tolerability, and Antiviral Activity of Repeated Oral Administration of AK0529 in Hospitalized Infants with Respiratory Syncytial Virus Infection","Main Inclusion criteria:\n\n1. Male or female subjects of any ethnicity with an age adjusted for any prematurity of ≥1 month and ≤24 months.\n2. Diagnosis of RSV infection by any virological means, including a rapid diagnostic point-of-care testing, within 36 hours preceding initial dosing.\n3. The onset of RSV infection symptoms should be ≤ 5 days prior to initial dosing.\n4. Subject must weigh ≥ 2.5 kg and ≤ 20 kg at screening and be within the normal range for the subject's age, based on local child growth standards.\n5. Subject must have a Wang bronchiolitis clinical score ≥ 5.\n\nMain Exclusion criteria:\n\n1. The subject has taken any restricted medications within 3 days prior to the date of screening or requires any restricted medications during treatment phase (including interferons, ribavirin, or proprietary Chinese medicines with antiviral effects) and has taken any inhaled or systemic glucocorticoids within 24 hours.\n2. Subject is known to have co-infection with influenza virus, Mycoplasma, or other respiratory tract pathogens that require targeted clinical treatment .\n3. Subject is known to have bacterial pneumonia.\n4. Subject with clinical evidence of hepatic decompensation (e.g., liver disease with coagulation abnormalities or encephalopathy).\n5. Subject with inborn symptoms of metabolic abnormalities (e.g., mitochondrial diseases, carbohydrate metabolism abnormalities, glycogen accumulation diseases).\n6. Subject with chronic or persistent feeding difficulties.\n7. The parent or guardian of the subject is an employee of the study investigator or the study facility (such person will be directly involved in the study or any other study administered by the study facility investigator), or a family member of the study investigator or his\u002Fher staff.\n8. Subject who have participated in clinical trials of other drugs or devices in the 30 days prior to screening.\n9. Subject with any other reason that the investigator deems unsuitable for participation in the study.","ALL","1 Month","24 Months",{"count":310,"type":311},180,"ESTIMATED","INTERVENTIONAL",[314],"PHASE3","Respiratory syncytial virus (RSV) is the most common respiratory infectious pathogen recognized worldwide that poses serious health risks to infants, and an important cause of hospitalization for severe respiratory infections in infants. Serious respiratory problems such as pneumonia caused by RSV are one of the leading causes of death from respiratory diseases in infants. AK0529 targets the Pre-F (fusion) protein on the surface of the viral envelope. Specifically, it prevents the virus from invading uninfected cells and inhibits the fusion between host cells by inhibiting the fusion of the F (fusion) proteins on the surface of the RSV envelope, thus providing the effects of anti-RSV infection. This is a randomized, double-blind, placebo-controlled, multicenter, phase III clinical study to evaluate the efficacy and safety of AK0529 in hospitalized infants aged 1 to 24 months with RSV infection. Considering the benefits of AK0529 in the population with RSV infection, hospitalized infants with moderate to severe RSV infection were selected as the target population for this study.",[317],"Respiratory Synctial Virus Infections","2025-01-09",{"date":320,"type":321},"2025-01-15","ACTUAL",{"date":323,"type":321},"2024-02-29",{"date":325,"type":311},"2025-09",{"name":5,"class":6},18]